A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity-Reference-Cited by-同舟云学术

A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity

Published:2022-01 Issue: Volume:228 Page:113983
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Tosh Dilip K.^ORCID,Salmaso Veronica,Campbell Ryan G.,Rao Harsha,Bitant Amelia,Pottie Eline^ORCID,Stove Christophe P.^ORCID,Liu Naili,Gavrilova Oksana^ORCID,Gao Zhan-Guo,Auchampach John A.,Jacobson Kenneth A.^ORCID

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

National Heart Lung and Blood Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference67 articles.

1. Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?;Borea;Trends Pharmacol. Sci.,2016

2. Physiology and effects of nucleosides in mice lacking all four adenosine receptors;Xiao;PLoS Biol.,2019

3. A3 adenosine receptors as modulators of inflammation: from medicinal chemistry to therapy;Jacobson;Med. Res. Rev.,2018

4. Therapeutic effect of oral CF101 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled Phase II study;Stoilov;Immunome Res.,2015

5. Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial;David;J. Eur. Acad. Dermatol. Venereol.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Substituted (N)-Methanocarba A₃ Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization;ACS Pharmacology & Translational Science;2024-06-06

2. Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective;Current Medicinal Chemistry;2024-02

3. First Potent Macrocyclic A₃ Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences;ACS Pharmacology & Translational Science;2023-08-08

4. “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies;Pharmaceuticals;2023-01-23

5. Structure–Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A₃ Adenosine Receptor Positive Allosteric Modulators;Journal of Medicinal Chemistry;2022-11-11